From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...
Destampasidis requested media coverage of the trial - Maria Marangelis, the former protected witness "Ekaterini Kelesi", is ...
Zacks Investment Research on MSN7h
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits FailureThis week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...
Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a ...
Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 ...
Trump announced tariffs of 10% on most US imports on Wednesday. However, he is imposing significantly higher tariffs on numerous countries with which the US has a large trade deficit, including ...
Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback